|Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article.|
1. L Bielory and MH Friedlaender. Allergic conjunctivitis. Immunol Allergy Clin North Am 2008; 28:43.
2. V Yaylali et al. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. Acta Ophthalmol Scand 2003; 81: 378.
3. M Discepola et al. Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis. Acta Ophthamol Scand Suppl 1999; 228:43.
4. FM Baroody et al. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol 2009; 123:1342.
5. Drugs for allergic disorders. Treat Guidel Med Lett 2010; 8:9.
6. G Torkildsen and A Shedden. The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis. Curr Med Res Opin 2011; 27:623.
7. JV Greiner et al. Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%. Clin Ophthalmol 2011; 5:87.